170 related articles for article (PubMed ID: 31945397)
21. Amyloid fibrils prepared using an acetylated and methyl amidated peptide model of the α-Synuclein NAC 71-82 amino acid stretch contain an additional cross-β structure also found in prion proteins.
Näsström T; Andersson PO; Lejon C; Karlsson BCG
Sci Rep; 2019 Nov; 9(1):15949. PubMed ID: 31685848
[TBL] [Abstract][Full Text] [Related]
22. Amyloid formation and disaggregation of α-synuclein and its tandem repeat (α-TR).
Bae SY; Kim S; Hwang H; Kim HK; Yoon HC; Kim JH; Lee S; Kim TD
Biochem Biophys Res Commun; 2010 Oct; 400(4):531-6. PubMed ID: 20801100
[TBL] [Abstract][Full Text] [Related]
23. The hot sites of α-synuclein in amyloid fibril formation.
Khammari A; Arab SS; Ejtehadi MR
Sci Rep; 2020 Jul; 10(1):12175. PubMed ID: 32699326
[TBL] [Abstract][Full Text] [Related]
24. Characterizing the inhibition of α-synuclein oligomerization by a pharmacological chaperone that prevents prion formation by the protein PrP.
Dong C; Garen CR; Mercier P; Petersen NO; Woodside MT
Protein Sci; 2019 Sep; 28(9):1690-1702. PubMed ID: 31306510
[TBL] [Abstract][Full Text] [Related]
25. Structures of segments of α-synuclein fused to maltose-binding protein suggest intermediate states during amyloid formation.
Zhao M; Cascio D; Sawaya MR; Eisenberg D
Protein Sci; 2011 Jun; 20(6):996-1004. PubMed ID: 21462277
[TBL] [Abstract][Full Text] [Related]
26. Modulation of α-synuclein fibrillization by ring-fused 2-pyridones: templation and inhibition involve oligomers with different structure.
Horvath I; Sellstedt M; Weise C; Nordvall LM; Krishna Prasad G; Olofsson A; Larsson G; Almqvist F; Wittung-Stafshede P
Arch Biochem Biophys; 2013 Apr; 532(2):84-90. PubMed ID: 23399432
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the 3D structures of mouse and human α-synuclein fibrils by solid-state NMR and STEM.
Hwang S; Fricke P; Zinke M; Giller K; Wall JS; Riedel D; Becker S; Lange A
J Struct Biol; 2019 Apr; 206(1):43-48. PubMed ID: 29678776
[TBL] [Abstract][Full Text] [Related]
28. Binding of Noradrenaline to Native and Intermediate States during the Fibrillation of α-Synuclein Leads to the Formation of Stable and Structured Cytotoxic Species.
Singh P; Bhat R
ACS Chem Neurosci; 2019 Jun; 10(6):2741-2755. PubMed ID: 30917654
[TBL] [Abstract][Full Text] [Related]
29. α-Synuclein Strains: Does Amyloid Conformation Explain the Heterogeneity of Synucleinopathies?
Hoppe SO; Uzunoğlu G; Nussbaum-Krammer C
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34201558
[TBL] [Abstract][Full Text] [Related]
30. Investigation of α-Synuclein Amyloid Fibrils Using the Fluorescent Probe Thioflavin T.
Sulatskaya AI; Rodina NP; Sulatsky MI; Povarova OI; Antifeeva IA; Kuznetsova IM; Turoverov KK
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142878
[TBL] [Abstract][Full Text] [Related]
31. The food additive fast green FCF inhibits α-synuclein aggregation, disassembles mature fibrils and protects against amyloid-induced neurotoxicity.
Wang F; Wang Y; Jiang L; Wang W; Sang J; Wang X; Lu F; Liu F
Food Funct; 2021 Jun; 12(12):5465-5477. PubMed ID: 33997868
[TBL] [Abstract][Full Text] [Related]
32. REMD Simulations of Full-Length Alpha-Synuclein Together with Ligands Reveal Binding Region and Effect on Amyloid Conversion.
Semenyuk PI
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232847
[TBL] [Abstract][Full Text] [Related]
33. Graphene-Based Nanoparticles as Potential Treatment Options for Parkinson's Disease: A Molecular Dynamics Study.
Alimohammadi E; Khedri M; Miri Jahromi A; Maleki R; Rezaian M
Int J Nanomedicine; 2020; 15():6887-6903. PubMed ID: 32982240
[TBL] [Abstract][Full Text] [Related]
34. Investigation on the Molecular Interactions Stabilizing the Structure of α-synuclein Fibril: An In silico Study.
Sanjeev A; Mattaparthi VSK
Cent Nerv Syst Agents Med Chem; 2017; 17(3):209-218. PubMed ID: 28460628
[TBL] [Abstract][Full Text] [Related]
35. Curcumin Pyrazole and its derivative (N-(3-Nitrophenylpyrazole) Curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of Wild type and Mutant α-Synuclein.
Ahsan N; Mishra S; Jain MK; Surolia A; Gupta S
Sci Rep; 2015 May; 5():9862. PubMed ID: 25985292
[TBL] [Abstract][Full Text] [Related]
36. Contact between the β1 and β2 Segments of α-Synuclein that Inhibits Amyloid Formation.
Shaykhalishahi H; Gauhar A; Wördehoff MM; Grüning CS; Klein AN; Bannach O; Stoldt M; Willbold D; Härd T; Hoyer W
Angew Chem Int Ed Engl; 2015 Jul; 54(30):8837-40. PubMed ID: 26119103
[TBL] [Abstract][Full Text] [Related]
37. Multiparametric fluorescence detection of early stages in the amyloid protein aggregation of pyrene-labeled alpha-synuclein.
Thirunavukkuarasu S; Jares-Erijman EA; Jovin TM
J Mol Biol; 2008 May; 378(5):1064-73. PubMed ID: 18433772
[TBL] [Abstract][Full Text] [Related]
38. The status of the terminal regions of α-synuclein in different forms of aggregates during fibrillization.
Marvian AT; Aliakbari F; Mohammad-Beigi H; Ahmadi ZA; Mehrpooyan S; Lermyte F; Nasouti M; Collingwood JF; Otzen DE; Morshedi D
Int J Biol Macromol; 2020 Jul; 155():543-550. PubMed ID: 32240735
[TBL] [Abstract][Full Text] [Related]
39. Alpha-synuclein phosphorylation induces amyloid conversion via enhanced electrostatic bridging: Insights from molecular modeling of the full-length protein.
Semenyuk PI
Biophys Chem; 2024 Apr; 307():107196. PubMed ID: 38335809
[TBL] [Abstract][Full Text] [Related]
40. Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity.
Carija A; Pinheiro F; Pujols J; Brás IC; Lázaro DF; Santambrogio C; Grandori R; Outeiro TF; Navarro S; Ventura S
Redox Biol; 2019 Apr; 22():101135. PubMed ID: 30769283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
